Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Washington state experiences historic flooding as Skagit River hits record high level. See flooding maps, highway closures and forecasts. - 2Astonishing interstellar comet captured in new images by NASA Mars missions
- 3Instructions to Perceive and Grasp the Early Side effects of Cellular breakdown in the lungs
- 4Fundamental Home Exercise center Hardware: Amplify Your Exercises
- 5The Best Business visionaries Under 30
- Authentic Urban areas: Rich Legacy and Lively Societies
- This Luxurious Thermal Spa In Italy Is Perfect For A Relaxing Escape While Visiting Milan
- Jamaica reports deadly leptospirosis outbreak after Hurricane Melissa
- An Aide On Upgrading Your FICO rating
- Miley Cyrus details her fear of paper, says fiancé Maxx Morando opens their packages outside: 'That's really why I got engaged'
- Ocean side Objections: Staggering Waterfront Breaks
- Reveal Less popular Authentic Realities You Didn't Learn in School
- The most effective method to Begin Your Excursion in Gold Venture
- Affordable Care Act enrollment is slightly ahead of last year, despite expiring subsidies
